TENX
Tenax Therapeutics, Inc.
There isn't enough reported data to score TENX yet.
TENX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Strong |
TENX's balance sheet is currently strong, but its profitability is weak. There isn't enough data to rate its revenue and cash flow.
TENX PE Valuation
TENX has no meaningful PE right now: it lost money over the past year.
TENX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| -- | |
| -- | |
| Limited | |
| Low |
Analysts expect TENX's earnings, revenue and profitability to hold roughly steady. However, they disagree widely on these estimates.
TENX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2022 | -$3,806.42 | +$1,389.95 |
| Q2 2022 | -$4,150.83 | +$1,093.54 |
| Q1 2022 | -$4,492.43 | +$959.94 |
| Q4 2021 | -$6,943.68 | -$3,507.31 |
| Q3 2021 | -$5,196.37 | -$610.16 |
| Q2 2021 | -$5,244.37 | -$418.16 |
| Q1 2021 | -$5,452.37 | -$546.16 |
| Q4 2020 | -$3,436.37 | +$1,389.84 |
TENX lost $1.15 per share over the past year, a smaller loss than the year before.
TENX Quarterly Revenue
TENX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$12.5M | -$3.3M |
| Q2 2026 | -$14.2M | -$7.9M |
| Q1 2026 | -$9.3M | -$2.3M |
| Q4 2025 | -$13.4M | -$9.9M |
| Q3 2025 | -$9.2M | -$6.1M |
| Q4 2024 | -$3.5M | -$2.4M |
| Q3 2024 | -$3.1M | -$1M |
| Q4 2023 | -$1.2M | +$1.1M |
TENX has burned cash in almost every quarter: −$49M over the past year, against −$26M the year before.
TENX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +1043% | +3.1M shares |
| 3 years | +31578% | +3.4M shares |
TENX has 3M diluted shares, up 1043% from a year ago.
TENX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2024 | -12.7x | Net Cash |
| Q2 2024 | -1.7x | Net Cash |
| Q1 2024 | -4.4x | Net Cash |
| Q4 2023 | -1.1x | Net Cash |
| Q3 2022 | -0.3x | Net Cash |
| Q2 2022 | -0.6x | Net Cash |
| Q1 2022 | -0.2x | Net Cash |
| Q4 2021 | -0.2x | Net Cash |
TENX has more cash than debt.
TENX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.0 | Oversold |
| Stochastic | 10.9 | Oversold |
TENX's weekly RSI is 29 (oversold) and its Stochastic is 11 (oversold).
TENX PE vs Healthcare Sector
TENX has no meaningful PE right now: it lost money over the past year.
TENX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.73 | 6.9% below |
| 20 week MA | $5.79 | 72% below |
| 50 week MA | $9.98 | 84% below |
| 100 week MA | $8.18 | 80% below |
| 200 week MA | $14.9 | 89% below |
TENX is in a downtrend: it's below all five of its weekly moving averages, and 89% below its 200-week average.
TENX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2,032.0 | $1,776.0 | -13% |
| 2021 | $1,776.0 | $1,792.0 | +0.9% |
| 2022 | $1,792.0 | $184.0 | -90% |
| 2023 | $184.0 | $22.0 | -88% |
| 2024 | $22.0 | $6.30 | -71% |
| 2025 | $6.30 | $12.7 | +101% |
| 2026 YTD | $12.7 | $1.61 | -87% |
TENX's yearly returns have swung widely, from +101% in 2025 to −90% in 2022. It's down 87% so far in 2026.